As of May 30, 2026, Lineage Cell Therapeutics's top three insider holders are Partners, L.P. Broadwood (Director, 49.56Mn shares), Brian M Culley (President And Ceo, 255.52K shares), Don M Bailey (Director, 158.80K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Don M Bailey | - | 0 | 158,801 | 08 Feb, 2024 |
| Partners, L.P. Broadwood | - | 49,560,992 | 0 | 28 Jan, 2025 |
| Brian M Culley | President And Ceo | 255,516 | 0 | 12 Mar, 2026 |
| Gary S. Hogge | Svp,Clinical Medical Affairs | 7,710 | 0 | 14 Feb, 2023 |
| Anula Jayasuriya | - | 10,000 | 0 | 02 Jan, 2024 |
| Dipti Amin | - | 35,000 | 0 | 29 Mar, 2022 |
| George A. Iii Samuel | General Counsel And Secretary | 31,063 | 0 | 13 Feb, 2026 |
| Jill Ann Howe | Chief Financial Officer | 25,500 | 0 | 26 Nov, 2024 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 12 Mar, 2026 | Brian M Culley | Common Shares | A | 15,000 | $1.63 | 255,516 | D | P |
| 05 Mar, 2026 | Brian M Culley | Employee Stock Option (Right to Buy) | A | 3,250,000 | $0.00 | 3,250,000 | D | A |
| 05 Mar, 2026 | George A. Iii Samuel | Employee Stock Option (Right to Buy) | A | 900,000 | $0.00 | 900,000 | D | A |
| 05 Mar, 2026 | George A. Iii Samuel | Employee Stock Option (Right to Buy) | A | 900,000 | $0.00 | 900,000 | D | A |
| 05 Mar, 2026 | Jill Ann Howe | Employee Stock Option (Right to Buy) | A | 1,050,000 | $0.00 | 1,050,000 | D | A |
| 05 Mar, 2026 | George A. Iii Samuel | Employee Stock Option (Right to Buy) | A | 900,000 | $0.00 | 900,000 | D | A |
| 11 Feb, 2026 | Brian M Culley | Common Shares | A | 31,250 | - | 253,385 | D | M |
| 11 Feb, 2026 | George A. Iii Samuel | Common Shares | A | 6,075 | - | 33,565 | D | M |
| 11 Feb, 2026 | George A. Iii Samuel | Common Shares | A | 6,075 | - | 33,565 | D | M |
| 11 Feb, 2026 | George A. Iii Samuel | Common Shares | A | 6,075 | - | 33,565 | D | M |
| 11 Feb, 2026 | George A. Iii Samuel | Common Shares | D | 2,502 | $1.80 | 31,063 | D | F |
| 11 Feb, 2026 | Brian M Culley | Common Shares | D | 12,869 | $1.80 | 240,516 | D | F |
| 11 Feb, 2026 | George A. Iii Samuel | Common Shares | D | 2,502 | $1.80 | 31,063 | D | F |
| 11 Feb, 2026 | George A. Iii Samuel | Common Shares | D | 2,502 | $1.80 | 31,063 | D | F |
| 11 Feb, 2026 | George A. Iii Samuel | Restricted Stock Units | D | 6,075 | $0.00 | 0 | D | M |
| 11 Feb, 2026 | George A. Iii Samuel | Restricted Stock Units | D | 6,075 | $0.00 | 0 | D | M |
| 11 Feb, 2026 | George A. Iii Samuel | Restricted Stock Units | D | 6,075 | $0.00 | 0 | D | M |
| 11 Feb, 2026 | Brian M Culley | Restricted Stock Units | D | 31,250 | $0.00 | 0 | D | M |
| 19 Dec, 2025 | George A. Iii Samuel | Common Shares | A | 1,735 | - | 27,555 | D | A |
| 19 Dec, 2025 | George A. Iii Samuel | Common Shares | A | 1,735 | - | 27,555 | D | A |